Genomics Collaborative Wins US Patent for Pneumonia Diagnostic; Product to Follow Within 1 Year | GenomeWeb

NEW YORK, Nov. 2 — Genomics Collaborative has been granted a patent for its community-acquired pneumonia diagnostic technology, the company said on Friday. 

The patent, based on an identifying a polymorphism linked with the tumor necrosis factor-alpha, is the company’s first and allows researchers to screen the genotypes of patients at risk for severe pneumonia and septic shock. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.